Genetic heterogeneity of HER2 has been associated with breast cancers with low-grade HER2 amplification (FISH score: >2.2 and <4.0) or equivocal cases including IHC (2+) HER2 expression [6,15]. Here, ERBB2 is linked to breast carcinoma.